검색어 : 통합검색[신영문]
총 1,916건 중 1,000건 출력
, 10/100 페이지
-
91
- Issue Information
- ; ; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e78)
-
92
- A lactate‐responsive gene signature predicts the prognosis and immunotherapeutic response of patients with triple‐negative breast cancer
- Feng, Kaixiang; Shao, Youcheng; Li, Jun; Guan, Xiaoqing; Liu, Qin; Hu, Meishun; Chu, Mengfei; Li, Hui; Chen, Fangfang; Yi, Zongbi; Zhang, Jingwei; Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors Hubei Cancer Clinical Study Center Wuhan China; Department of Pathology and Pathophysiology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, TaiKang Medical School (School of Basic Medical Sciences) Wuhan University Wuhan China; Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors Hubei Cancer Clinical Study Center Wuhan China; Department of Pathology and Pathophysiology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, TaiKang Medical School (School of Basic Medical Sciences) Wuhan University Wuhan China; Department of Pathology and Pathophysiology, Hubei Provincial Key Laboratory of Developmentally Originated Disease, TaiKang Medical School (School of Basic Medical Sciences) Wuhan University Wuhan China; Department of Breast an; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e124)
-
93
- Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta‐analysis
- Xie, Ruiyang; Wu, Jie; Shang, Bingqing; Bi, Xingang; Cao, Chuanzhen; Guan, Youyan; Shi, Hongzhe; Shou, Jianzhong; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Department of Urology, National Cancer C; (Cancer innovation = 腫瘤創新 (英文), v.1, 2022, pp.293-304)
-
94
- Novel progressive deep learning algorithm for uncovering multiple single nucleotide polymorphism interactions to predict paclitaxel clearance in patients with nonsmall cell lung cancer
- Chen, Wei; Zhou, Haiyan; Zhang, Mingyu; Shi, Yafei; Li, Taifeng; Qian, Di; Yang, Jun; Yu, Feng; Li, Guohui; School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing China; Pharmacy Department, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Pharmacy Department, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Pharmacy Department, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Pharmacy Department, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Pharmacy Department, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; Pharmacy Department, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; School of Basic Medicine and Clinic; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e110)
-
95
- Breast cancer immunotherapy: Realities and advances
- Medina, Aixa; Carballo, Jeismar; Gonzá lez‐ Marcano, Eglys; Blanca, Isaac; Convit, Ana F.; Jacinto Convit World Organization Inc. Pompano Beach Florida USA; Jacinto Convit World Organization Inc. Pompano Beach Florida USA; Jacinto Convit World Organization Inc. Pompano Beach Florida USA; Unidad Experimental de Inmunoterapia Fundació n Jacinto Convit Caracas Venezuela; Jacinto Convit World Organization Inc. Pompano Beach Florida USA; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e140)
-
96
- Role of liquid-liquid phase separation in cancer: Mechanisms and therapeutic implications
- Li, Xuesong; Yu, Zhuo; School of Clinical Medicine Tsinghua University Beijing China; Department of Medical Oncology Beijing Tsinghua Changgung Hospital Beijing China; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e144)
-
97
- Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping review
- Ghasemi, Amirehsan; Hashtarkhani, Soheil; Schwartz, David L.; Shaban‐ Nejad, Arash; Department of Pediatrics, Center for Biomedical Informatics, College of Medicine University of Tennessee Health Science Center Memphis Tennessee USA; Department of Pediatrics, Center for Biomedical Informatics, College of Medicine University of Tennessee Health Science Center Memphis Tennessee USA; Department of Radiation Oncology, College of Medicine University of Tennessee Health Science Center Memphis Tennessee USA; Department of Pediatrics, Center for Biomedical Informatics, College of Medicine University of Tennessee Health Science Center Memphis Tennessee USA; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e136)
-
98
- Inhibition of Putative Ibrutinib Targets Promotes Atrial Fibrillation, Conduction Blocks, and Proarrhythmic Electrocardiogram Indices: A Mendelian Randomization Analysis
- Xu, Hongxuan; Li, Bingxun; Lv, Pinchao; Chen, Ying; Lin, Yanyun; Zhang, An; Zhao, Jing; Zhou, Guoxiong; Wu, Lin; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; Department of Cardiology Peking University First Hospital Beijing China; (Cancer innovation = 腫瘤創新 (英文), v.4, 2025, pp.e70004)
-
99
- Issue Information
- ; ; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e81)
-
100
- Histone deacetylase 6 as a novel promising target to treat cardiovascular disease
- Wu, Ya‐ Xi; Li, Bing‐ Qian; Yu, Xiao‐ Qian; Liu, Yu‐ Lin; Chui, Rui‐ Hao; Sun, Kai; Geng, Dian‐ Guang; Ma, Li‐ Ying; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Science and Institute of Pharmaceutical Science Zhengzhou University Zhengzhou Henan China; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Science and Institute of Pharmaceutical Science Zhengzhou University Zhengzhou Henan China; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Science and Institute of Pharmaceutical Science Zhengzhou University Zhengzhou Henan China; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Scien; (Cancer innovation = 腫瘤創新 (英文), v.3, 2024, pp.e114)
QUICK MENU
